Company / SG&A Expense
Heartflow, Inc. SG&A Expense History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$134.3M
FY2025
5-year range
$134.3M / $134.3M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#126 of 158
Health Care
What the data says
Heartflow, Inc.'s sg&a expense of $134M is lower than 80% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$134M in FY2025.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 158This company $134.3M Sector average $175.9B
▼
-99.9% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $134.3M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026